Funding for this research was provided by:
Schweizerische Akademie der Medizinischen Wissenschaften (KZS 20/17, KZS 20/17, KZS 20/17)
Received: 4 December 2020
Accepted: 9 April 2021
First Online: 2 July 2021
: This study has been conducted in compliance with the current version of the Declaration of Helsinki, the ICH-GCP or ISO EN 14155 (as far as applicable) as well as all national legal and regulatory requirements. Prior to recruitment, the study protocol obtained a waiver (in local terminology: statement of non-objection) from the Cantonal Ethics Committee of Canton Zurich (BASEC-Nr. Re1-2018-00638) and the Ethics Committee Northwest/Central Switzerland (Req-2018-00637) both confirming that the study does not fall under the Human Research Act (HRA). Based on the Committees clarification of responsibility of multicenter projects, no additional approval from other sites was required. A written informed consent was obtained from the interviewees prior to the interviews. Extensive information about the study (what data will be collected, how, by whom and for what purposes) was provided orally and in written form by the interviewer. No monetary compensation for participants is being provided. All study participants were given the opportunity to withdraw their consent at any time.
: Not applicable.
: Dr. Ienca and Dr. Kressig have served as independent expert advisors for Clever.Care AG. However, they have not received any private sector funding for the realisation of this study.